The goal of this pilot randomized clinical trial is to learn if Neurobehavioral Therapy (NBT) works to treat motor functional neurological disorder (mFND) (also referred to as functional motor disorder). The main questions it aims to answer are: * Does NBT lower mFND symptoms? * Does NBT lower common co-occurring symptoms and improve functioning? Researchers will compare NBT to standard medical care (SMC). Participants will be randomized to receive either: * 12 weekly sessions of NBT, along with their SMC, * or continue receiving their SMC as provided by their treating clinicians. * all participants. regardless of group assignment, will complete a total of five in-clinic visits at the following time points: Baseline, 6 weeks, 12 weeks, 8 Months and 12 Months for self-report surveys to assess functional status, quality of life and mFND symptoms.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
SF-36 Health Survey (SF-36)
Timeframe: Baseline, Week 6, Week 12, 8 Months and 12 Months
Psychogenic Movement Disorders Rating Scale (PMDRS)
Timeframe: Baseline, Week 6, Week 12, 8 Months and 12 Months
Simplified Functional Movement Disorders Rating Scale (S-FMDRS)
Timeframe: Baseline, Week 6, Week 12, 8 Months and 12 Months